ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Excelsior Sciences
Excelsior Sciences is transforming drug discovery with modular chemistry and automated workflows to create better medicines faster.
Company Size
1-10 employees
Excelsior Sciences leverages blocc chemistry — automated, AI-friendly small molecule synthesis — to accelerate drug discovery and scale from molecule to manufacturing. Their platform uses machine-ready chemical building blocks and closed-loop AI-guided synthesis to transform small-molecule innovation into a modular, iterative process accessible to automation and non-specialists. The company operates at the intersection of chemistry and AI, targeting pharmaceuticals and broader materials applications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Excelsior Sciences.
16% above the average for this role
Back End Developer
Vodafone Deutschland
Principal Lead, Digital Workplace Intelligent Operations
Equinix
Scientist, Computational Chemistry, Drug Discovery
Lila Sciences
Vice President, Early Discovery Chemistry
Revolution Medicines
Field Application Scientist (LIMS)
Veracyte
Associate Director, Drug Substance, Biologics
Formation Bio